Amalgamated Bank’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Amalgamated Bank’s Portfolio TBIO Stock Details TBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-11,086	Closed	-$305K	–	2190
2021 Q2	$305K	Buy	+11,086	New	+$218K	﹤0.01%	1878
2021 Q1	–	Sell	-10,652	Closed	-$196K	–	1634
2020 Q4	$196K	Buy	10,652 +62	+0.6%	+$1.11K	0.01%	1455
2020 Q3	$144K	Buy	+10,590	New	+$163K	0.01%	1362

Amalgamated Bank's TBIO Position: Q3 2021 in Review

Amalgamated Bank sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 11,086 shares — an estimated $305K sold.

Amalgamated Bank first reported a position in TBIO in Q3 2020 and held it in 3 quarters. The position peaked at $305K in Q2 2021. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

Amalgamated Bank reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
Amalgamated Bank sold 11,086 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $305K.
Amalgamated Bank first reported a position in Translate Bio, Inc. Common Stock in Q3 2020 and held it in 3 quarters.
Amalgamated Bank's Translate Bio, Inc. Common Stock position peaked at $305K in Q2 2021.
0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.

Based on Amalgamated Bank's 13F filing for Q3 2021, filed 29 Oct 2021.